- Filed
- Mar 31, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 31, 2026 | 811.45K sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 443.37K sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 31.82K sh |
| Capex | FY 2025 · Dec 31, 2025 | $18.18K |
| Capex | FY 2025 · Dec 31, 2024 | $4.19K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$13.81M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$17.11M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $7.2M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $6.46M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $4.52M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $6.18M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | −$4.43M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $4.1M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $2.52M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $4.1M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $2.52M |
| Current Assets | FY 2025 · Dec 31, 2025 | $8.1M |
| Current Assets | FY 2025 · Dec 31, 2024 | $8.66M |
| Total Assets | FY 2025 · Dec 31, 2025 | $8.62M |
| Total Assets | FY 2025 · Dec 31, 2024 | $8.7M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$35.75 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$466.89 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$35.75 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$466.89 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $6.21M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $5.61M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $9.77M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $9.29M |
| Net Income | FY 2025 · Dec 31, 2025 | −$15.85M |
| Net Income | FY 2025 · Dec 31, 2024 | −$14.86M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$15.99M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$14.9M |